ABEO
ABEO
NASDAQ · Biotechnology

Abeona Therapeutics Inc

$5.13
+0.23 (+4.69%)
As of Feb 8, 2:00 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +174.7% upside
Low Target $7.81
Average Target $14.09
High Target $15.42
Current Price $5.13
Current
$5.13
Target
$14.09
$7.81 $14.09 avg $15.42
Scenario Analysis
Bear Case
$7.81
52.2%
Low target
Base Case
$14.09
+174.7%
Avg target
Bull Case
$15.42
+200.6%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$15.27
-66.4% from high
52-Week Low
$9.89
+-48.1% from low
Target vs 52W High
$14.09
-7.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%